BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2238036)

  • 1. HLA-matched blood products and posttransfusion graft-versus-host disease.
    Charpentier F; Bracq C; Bonin P; Berling P; Duedari N
    Transfusion; 1990; 30(9):850. PubMed ID: 2238036
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular kinetics of posttransfusion graft-versus-host disease after heart operations.
    Mayumi H; Matsui K; Matsuzaki K; Uchida T; Shinozaki K; Tokunaga K
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):179-82. PubMed ID: 8028366
    [No Abstract]   [Full Text] [Related]  

  • 3. Amplified fragment length polymorphism analysis in the evaluation of posttransfusion graft-versus-host disease in a child undergoing extracorporeal membrane oxygenation.
    DePalma L; Bahrami KR; Kapur S; Short BL; Luban NL
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):182-4. PubMed ID: 7913148
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
    Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
    Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts.
    Vogelsang GB
    Transfusion; 1990 Feb; 30(2):101-3. PubMed ID: 2137651
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion-associated graft-versus-host disease in an immunocompetent patient.
    Capon SM; DePond WD; Tyan DB; Pepkowitz SH; Toyoda H; Cinman AC; Azer PC; Goldfinger D
    Ann Intern Med; 1991 Jun; 114(12):1025-6. PubMed ID: 2029098
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid molecular diagnosis of posttransfusion graft-versus-host disease by polymerase chain reaction.
    Hayakawa S; Chishima F; Sakata H; Fujii K; Ohtani K; Kurashina K; Hayakawa J; Suzuki K; Nakabayashi H; Esumi M
    Transfusion; 1993 May; 33(5):413-7. PubMed ID: 8488546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransfusion graft-versus-host disease in Japanese newborns.
    Ohto H; Anderson KC
    Transfusion; 1996 Feb; 36(2):117-23. PubMed ID: 8614960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft versus host disease following transfusion of normal blood products to patients with malignancies.
    Kessinger A; Armitage JO; Klassen LW; Landmark JD; Hayes JM; Larsen AE; Purtilo DT
    J Surg Oncol; 1987 Nov; 36(3):206-9. PubMed ID: 3316850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransfusion graft-versus-host disease in immunocompetent patients.
    Brubaker DB
    Transfusion; 1994 Jul; 34(7):647-8. PubMed ID: 8053045
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR.
    Blundell EL; Pamphilon DH; Anderson NA; Slade RR; Burton PA; Martin A; Ray T; Bradley BA; Lawler M; Humphries P
    Br J Haematol; 1992 Nov; 82(3):622-3. PubMed ID: 1486045
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease: scratching the surface.
    Shivdasani RA; Anderson KC
    Transfusion; 1993 Sep; 33(9):696-7. PubMed ID: 8212111
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
    McMilin KD; Johnson RL
    Transfus Med Rev; 1993 Jan; 7(1):37-41. PubMed ID: 8431657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenic mechanisms of posttransfusion graft-vs-host disease.
    Brubaker DB
    Proc Soc Exp Biol Med; 1993 Feb; 202(2):122-47. PubMed ID: 8424102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal posttransfusion graft-versus-host disease. Report of four cases.
    Matsumoto K; Kubo H; Saida T; Kobayashi H; Kitano K; Saito H; Matsui M
    Dermatology; 1993; 187(1):38-41. PubMed ID: 8324276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusions and graft-vs-host disease.
    Ray TL
    Arch Dermatol; 1990 Oct; 126(10):1347-50. PubMed ID: 2221941
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal transfusion-associated graft-vs-host disease.
    Otsuka S; Kasuya S; Hirose M
    Aust N Z J Med; 1993 Jun; 23(3):308-9. PubMed ID: 8352710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.